These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22674598)

  • 21. The effectiveness of therapeutic interventions on quality of life for vitiligo patients: a systematic review.
    Chan MF; Chua TL
    Int J Nurs Pract; 2012 Aug; 18(4):396-405. PubMed ID: 22845640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond Traditional Treatment: The Importance of Psychosocial Therapy in Vitiligo.
    Rzepecki AK; McLellan BN; Elbuluk N
    J Drugs Dermatol; 2018 Jun; 17(6):688-691. PubMed ID: 29879259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life among Malaysian patients with vitiligo.
    Wong SM; Baba R
    Int J Dermatol; 2012 Feb; 51(2):158-61. PubMed ID: 22250623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study.
    Oliveira FAP; Santos FMMD; Dias AFMP; Neiva CLS; Telles RW; Lanna CCD
    Lupus; 2020 Oct; 29(11):1438-1448. PubMed ID: 32757736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening.
    Grau C; Silverberg NB
    Cutis; 2013 May; 91(5):248-52. PubMed ID: 23772431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitiligo. Pathogenesis and treatment.
    Njoo MD; Westerhof W
    Am J Clin Dermatol; 2001; 2(3):167-81. PubMed ID: 11705094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depigmentation of the normally pigmented patches in universal vitiligo patients by cryotherapy.
    Radmanesh M
    J Eur Acad Dermatol Venereol; 2000 May; 14(3):149-52. PubMed ID: 11032055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an antioxydant cream versus placebo in patients with vitiligo in association with excimer laser. A pilot randomized, investigator-blinded, and half-side comparison trial.
    Leone G; Paro Vidolin A
    G Ital Dermatol Venereol; 2015 Aug; 150(4):461-6. PubMed ID: 26224232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guideline for the diagnosis and management of vitiligo.
    Gawkrodger DJ; Ormerod AD; Shaw L; Mauri-Sole I; Whitton ME; Watts MJ; Anstey AV; Ingham J; Young K; ; ; ;
    Br J Dermatol; 2008 Nov; 159(5):1051-76. PubMed ID: 19036036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo.
    Rao J; Fitzpatrick RE
    Dermatol Surg; 2004 Jul; 30(7):1043-5. PubMed ID: 15209798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool.
    Salzes C; Abadie S; Seneschal J; Whitton M; Meurant JM; Jouary T; Ballanger F; Boralevi F; Taieb A; Taieb C; Ezzedine K
    J Invest Dermatol; 2016 Jan; 136(1):52-8. PubMed ID: 26763423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitiligo: an under-estimated problem.
    Agarwal G
    Fam Pract; 1998 Apr; 15 Suppl 1():S19-23. PubMed ID: 9613463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Randomized Double Blind Clinical Trial on a Sabgh Formulation for Patients With Vitiligo.
    Hosseinkhani A; Montaseri H; Sodaifi M; Mohagheghzadeh A; Seradj H; Afshari-Jouybari H
    J Evid Based Complementary Altern Med; 2015 Oct; 20(4):254-8. PubMed ID: 25851025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment and Comparison of Quality of Life in Patients with Melasma and Vitiligo.
    Amatya B; Pokhrel DB
    Kathmandu Univ Med J (KUMJ); 2019; 17(66):114-118. PubMed ID: 32632057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial effects of vitiligo.
    Ongenae K; Beelaert L; van Geel N; Naeyaert JM
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):1-8. PubMed ID: 16405601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser.
    Njoo MD; Vodegel RM; Westerhof W
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):760-9. PubMed ID: 10775851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitiligo.
    Le Poole C; Boissy RE
    Semin Cutan Med Surg; 1997 Mar; 16(1):3-14. PubMed ID: 9125760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Life quality assessment among patients with vitiligo: comparison of married and single patients in Iran.
    Dolatshahi M; Ghazi P; Feizy V; Hemami MR
    Indian J Dermatol Venereol Leprol; 2008; 74(6):700. PubMed ID: 19177700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitiligo: a review of the published work.
    Yaghoobi R; Omidian M; Bagherani N
    J Dermatol; 2011 May; 38(5):419-31. PubMed ID: 21667529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of vitiligo: patient characteristics associated with quality of life.
    Linthorst Homan MW; Spuls PI; de Korte J; Bos JD; Sprangers MA; van der Veen JP
    J Am Acad Dermatol; 2009 Sep; 61(3):411-20. PubMed ID: 19577331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.